PAREXEL International Corp. has appointed several executives to its global team of late phase and observational research experts in its PACE (Peri-Approval Clinical Excellence) group. The team will help sponsors collect the data they need to meet commercialization goals. Peggy Schrammel will serve as vice president and global head portfolio management, PACE. Ms. Schrammel’s experience includes senior-level positions at major CROs, where she designed and managed late phase programs includi...